Citius Pharmaceuticals Inc. Common (CTXR) Total Assets by Year
Citius Pharmaceuticals Inc. Common closed fiscal year 2025 with $130.9M in total assets, $53.4M in total liabilities and $67.6M in shareholder equity. This represents an increase of 12.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Citius Pharmaceuticals Inc. Common has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CTXR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $130.9M+12.2% | $116.7M+12.6% | $103.6M-9.1% | $114.0M-20.0% | $142.4M+225.4% | $43.8M+19.1% | $36.7M+18.3% | $31.1M+27.2% | $24.4M+11.2% | $22.0M+2860.1% | $742K-52.4% | $1.6M | $0-100.0% | $135-36.3% | $212 |
| Total Liabilities | $53.4M+25.5% | $42.5M+249.4% | $12.2M+15.2% | $10.6M+9.6% | $9.6M-4.5% | $10.1M+5.3% | $9.6M+2236.2% | $411K-83.4% | $2.5M-52.4% | $5.2M+276.5% | $1.4M-40.1% | $2.3M+15548.5% | $15K-68.0% | $46K+91.2% | $24K |
| Total Equity | $67.6M-3.6% | $70.1M-22.8% | $90.8M-11.7% | $102.8M-22.2% | $132.2M+292.6% | $33.7M+24.0% | $27.2M-11.4% | $30.6M+39.6% | $21.9M+30.9% | $16.8M+2739.5% | -$635K+14.4% | -$742K-4949.2% | -$15K+67.9% | -$46K-92.3% | -$24K |
CTXR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $142.3M+11.4% | $132.5M+9.1% | $140.4M+16.3% | $130.9M+12.2% | $127.7M+31.5% | $121.5M+33.9% | $120.7M+23.9% | $116.7M+12.6% | $97.1M-12.1% | $90.7M-13.0% | $97.4M-12.8% | $103.6M-9.1% |
| Total Liabilities | $66.3M+10.4% | $63.5M+9.6% | $46.9M-9.4% | $53.4M+25.5% | $60.1M+456.3% | $57.9M+438.9% | $51.8M+329.2% | $42.5M+249.4% | $10.8M-10.7% | $10.7M-13.6% | $12.1M+13.1% | $12.2M+15.2% |
| Total Equity | $66.6M+2.4% | $61.5M+1.5% | $80.0M+22.2% | $67.6M-3.6% | $65.1M-24.1% | $60.7M-23.6% | $65.4M-22.8% | $70.1M-22.8% | $85.7M-12.3% | $79.4M-13.0% | $84.7M-15.6% | $90.8M-11.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Citius Pharmaceuticals Inc. Common financials
Frequently Asked Questions
What was Citius Pharmaceuticals Inc. Common's total assets in fiscal year 2025?
Citius Pharmaceuticals Inc. Common closed fiscal year 2025 with $130.9M in total assets, $53.4M in total liabilities and $67.6M in shareholder equity.
How fast is Citius Pharmaceuticals Inc. Common's total assets growing?
Citius Pharmaceuticals Inc. Common (CTXR) total assets rose by 12.2% year over year, from $116.7M to $130.9M in fiscal year 2025.
How has Citius Pharmaceuticals Inc. Common's total assets changed over the years?
Across the 15 fiscal years this page covers, Citius Pharmaceuticals Inc. Common (CTXR) total assets went from $212 in fiscal year 2011 to $130.9M in fiscal year 2025.
What was Citius Pharmaceuticals Inc. Common's total assets in the most recent quarter?
Citius Pharmaceuticals Inc. Common (CTXR) reported $142.3M in total assets in Q3 2026. This represents an increase of 11.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Citius Pharmaceuticals Inc. Common (CTXR) reported on that line in every period on record.